Pursuant to the posting earlier this week which noted the rate of drug safety alerts out of the FDA, there also this week was a story published at CNNMoney.com that raises the very valid question whether or not patients and … Continue reading
In recent weeks, policymakers have turned up the heat on the FDA. First, Congressman Bart Stupak (D-MI) sent Dr. Andrew C. von Eschenbach a Valentine by demanding his resignation on February 14. Less than a week later, Congresswoman Rosa DeLauro … Continue reading
The Health Section of today’s Washington Post runs a story called "Why All the Drug Alerts? Step-Up Signals FDA Bid for Renewed Trust" which focuses on the uptick in FDA safety alerts about drugs. The uptick that the Post notes … Continue reading
Late last month, the National Health Policy Forum published a background paper called Pharmacogenomics: A Primer for Policymakers written by Leslie Tucker. It is a really excellent overview of the state of the state on pharmacogenomics and as the title … Continue reading
Inside the Beltway it is cold, foggy and icy. Hopefully where you are, it is warm and pleasant. This week I posted on the listing of approvable letters for 2007. This proved an immensely popular posting, I am happy to … Continue reading
